Hotspot


Life Sciences | 1998

A POTENT NONPEPTIDE NEUROPEPTIDE Y Y1 RECEPTOR ANTAGONIST. A BENZODIAZEPINE DERIVATIVE

Yasushi Shigeri; Michio Ishikawa; Yasunobu Ishihara; Masafumi Fujimoto

We describe here a nonpeptide neuropeptide Y Y1 receptor antagonist, 2,4-dioxo-1,5-bis(2-oxo-2-orthotolyl-ethyl)-3-[3-[3-([3-[3-(3-p iperidin-1-ylmethyl-phenoxy)-propylcarbamoyl]-propyl]-car bamoyloxymethyl)-phenyl]-ureido]-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diaz epine (Compound 1), which was previously synthesized as a linked type of dual cholecystokinin (CCK)-B and histamine H2 receptor antagonist. Compound 1 competitively inhibited [125I]peptide YY (PYY) binding to Y1 receptors in human neuroblastoma SK-N-MC cells with Ki of 6.4 +/- 1.0 nM, while it had no effect on [125I]PYY binding to Y2 or Y5 receptors even at 1 microM. Functionally, Compound 1 inhibited the Y1 receptor-mediated increase in cytosolic free Ca2+ concentration and Y1 receptor-mediated attenuation of cAMP accumulation in a dose-dependent manner with IC50 values of 95 +/- 5 and 320 +/- 10 nM in SK-N-MC cells, respectively. Neither its CCK-B receptor antagonistic moiety of Compound 1 (Compound 2) nor its histamine H2 receptor antagonistic moiety of Compound 1 (Compound 3) had any effect on [125I]PYY binding, suggesting that the entire structure of Compound 1 is essential for Y1 receptor blocking activity. It showed no significant activity (IC50 > 1 microM) in 30 receptor binding assays and 5 enzyme assays, with the exception of CCK-B and histamine H2 receptors. We conclude that Compound 1 is a useful molecule not only for studying the physiological role of neuropeptide Y but also for exploring more specific Y1 receptor antagonists.


Chemical & Pharmaceutical Bulletin | 1997

Synthesis and Biological Evaluation of a New Reversely Linked Type of Dual Histamine H2 and Gastrin Receptor Antagonist

Yasuyuki Kawanishi; Shoichi Ishihara; Kimio Takahashi; Tadahiko Tsushima; Sanji Hagishita; Michio Ishikawa; Yasunobu Ishihara


Chemical & Pharmaceutical Bulletin | 1984

Antivertigo Agents. I. Structure-Activity Relationships of 2-(2-Aminoethyl) pyridines

Akira Shiozawa; Yuhichiro Ichikawa; Chikara Komuro; Genichi Idzu; Michio Ishikawa; Shuji Kurashige; Hiroshi Miyazaki; Hiroshi Yamanaka; Takao Sakamoto


Archive | 1987

Derivatives of an aminoketone

Akira Shiozawa; Michio Ishikawa; Giichi Izumi; Katsuhiko Sakitama; Kazuhisa Narita; Shuji Kurashige; Takeji Sakasai; Kazuo Ohtsuki; Hideo Sugimura; Hirotaka Yamamoto


Archive | 1986

New derivatives of an aminoketone

Akira Shiozawa; Michio Ishikawa; Giichi Izumi; Katsuhiko Sakitama; Kazuhisa Narita; Shuji Kurashige


Chemical & Pharmaceutical Bulletin | 1984

Antivertigo agents. II. Structure-activity relationships of 6-substituted 5,6,7,8-tetrahydro-1,6-naphthyridines.

Akira Shiozawa; Yuh-Ichiro Ichikawa; Michio Ishikawa; Yoshiya Kogo; Shuji Kurashige; Hiroshi Miyazaki; Hiroshi Yamanaka; Takao Sakamoto


Archive | 1987

An optically active propanone derivative and process for producing the same and use thereof

Akira Shiozawa; Michio Ishikawa; Hideo Sugimura; Kazuhisa Narita; Hirotaka Yamamoto; Takeji Sakasai; Kazuo Ohtsuki; Shuji Kurashige


Chemical & Pharmaceutical Bulletin | 1984

Antivertigo Agents. IV. Synthesis and Antivertigo Activity of 6-[ω-(4-Aryl-1-piperazinyl) alkyl]-5,6,7,8-tetrahydro-1,6-naphthyridines

Akira Shiozawa; Yuhichiro Ichikawa; Chikara Komuro; Michio Ishikawa; Yasuhiko Furuta; Shuji Kurashige; Hiroshi Miyazaki; Hiroshi Yamanaka; Takao Sakamoto


Chemical & Pharmaceutical Bulletin | 1985

Antivertigo Agents. V. Quantitative Structure-Activity Relationships of 6-[2-(4-Aryl-1-piperazinyl) ethyl]-5, 6, 7, 8-tetrahydro-1, 6-naphthyridines

Akira Shiozawa; Yoshiya Kogo; Yuhichiro Ichikawa; Chikara Komuro; Michio Ishikawa; Shuji Kurashige; Hiroshi Miyazaki; Hiroshi Yamanaka; Takao Sakamoto


Archive | 1987

Optisch aktives propanon-derivat, verfahren zu seiner herstellung und seine verwendung. Optically active propanone derivative, process for its preparation and its use.

Akira Shiozawa; Michio Ishikawa; Hideo Sugimura; Kazuhisa Narita; Hirotaka Yamamoto; Takeji Sakasai; Kazuo Ohtsuki; Shuji Kurashige

Researchain Logo
Decentralizing Knowledge